was born on February 17, 1949, in Leuven.
He grew up in the small farming village of Keerbergen, Belgium. As a young man he was already interested in physics and mathematics as well as disease and social injustice. His interest in the latter field was inspired by the missionary work of Father Damien, a priest born in 1840 in Tremelo (near Keerbergen), renowned for his service to Hawaiian lepers. After enrolling at the University of Ghent to study engineering,
He changed his focus to medicine, obtaining a medical degree in 1974.
After completing his medical studies, he worked as a research assistant at the Institute of Tropical Medicine in Antwerp where, in 1976, he was part of the Belgian team that was one of the first to isolate the Ebola virus. Belgian researchers discovered the virus in a blood specimen from a Belgian nun who had been to Zaire (now the Democratic Republic of the Congo). Shortly after the discovery, Piot was sent to Zaire. He was part of a small group of doctors and scientists sent to investigate an outbreak possibly associated with the virus. The outbreak turned out to be the first recognized epidemic of the Ebola virus disease.
In the late 70s, Piot began his postgraduate studies in microbiology at the University of Antwerp. In 1978 he received a scholarship to study in the United States. He spent most of his stay in that country at the University of Washington in Seattle, working with epidemiologist King Holmes on the study of sexually transmitted diseases (STDs). After completing his studies at Ph.D. In 1980, Piot returned to the Institute of Tropical Medicine, where he continued to research STDs.
In the early eighties Piot was interested in a subset of patients from the Antwerp institute who had been affected by rare opportunistic infections. The vast majority of the patients came from Central Africa. However, the characteristics of his disease were similar to those seen in a small handful of American patients, whose cases had been described in a report published in 1981 by the United States Center for Disease Control. The report detailed the cases of a rare lung infection that was associated with an immune deficiency – later known as AIDS – in a subgroup of gay men.
Following the connection between the cases in Belgium and Africa and wanting to know more about the modes of transmission of HIV (the causative agent of AIDS), he returned to Zaire in 1983. At that time, it was widely believed that AIDS was limited to Communities. of gay men; some researchers even considered naming it gay-related immune deficiency syndrome (GRID). But in both Africa and Antwerp, Piot and his colleagues documented AIDS cases among heterosexual men and women, observations that were critical in dispelling the notion that HIV / AIDS was only a male homosexual disease.
In the mid-1980s Piot he continued to study HIV / AIDS in Zaire and other parts of Africa. He oversaw multiple collaborative research projects and was a co-promoter of the AIDS Project, the first international AIDS research program, launched in 1984. Through these efforts, he played key roles in describing the epidemiology of HIV / AIDS in Africa and in identifying genomic variation in HIV. It also helped develop interventions to prevent the spread of the virus. Piot did some of his work on AIDS at the University of Nairobi in Kenya, where he briefly served as a professor of medical microbiology.
Piot it was reestablished in Antwerp in the late 1980s; for a time he was chair of the department of microbiology and immunology at the Institute of Tropical Medicine. He also participated in work on AIDS led by the World Health Organization (WHO), marking the beginning of his transition from research to the realm of public health and policy. Piot He became fully committed to AIDS policy in 1992, when he joined WHO’s Global AIDS Program (GPA) as Associate Director. Since 1987 the GPA (known in 1987 as the Special Program on AIDS) had led the global response to AIDS, having been assigned that leadership role by the UN General Assembly. The GPA had helped provide financial support to countries to fight AIDS, but when Piot took office, due to the economic downturn in the West, he demonstrated the need for UN reform; furthermore, infighting between the WHO and other UN agencies heralded the demise of the program.
Seeking greater involvement of agencies and donors than was possible through WHO, officials set to work developing a new UN-based program, UNAIDS. Piot he was selected to lead the new program, in large part because of his work on AIDS in Africa. He was also one of the few individuals who gained that experience by holding a relatively neutral position within the political spheres of the WHO and various UN agencies.
During his tenure at the UN, Piot He became the world’s leading AIDS activist and successfully brought together a number of entities in the fight against AIDS, from UN agencies and national governments to non-governmental organizations and businesses. He worked with national leaders, involving them in decisions about how to deal with the AIDS epidemic in their countries, and he worked to increase annual global spending on AIDS, persuading donor countries to collectively contribute billions of dollars at the turn of the century. XXI, to quell the AIDS epidemic in Africa. Piot also successfully participated in pharmaceutical companies, which agreed to mass-distribute antiretroviral drugs at significantly reduced costs, in less developed regions.
Piot He served as Executive Director of UNAIDS and UN Under-Secretary-General until 2008. Subsequently, he was Director of the Institute for Global Health and Professor of Global Health at the Imperial College of Science, Technology and Medicine, London (2009-10) and Professor Global Health Officer and Director of the London School of Hygiene and Tropical Medicine (since 2010).
He was president of the International AIDS Society (1992-94) and a board member of several global health initiatives. In 1995 he was awarded the title of baron by the Belgian King Albert II. Piot was an elected member of several academies, including the Royal College of Physicians and the United States National Academy of Sciences, and was the recipient of numerous awards, including the Nelson Mandela Prize for Health and Human Rights (2001). His book of memories “No time to waste: a life in search of deadly viruses“was published in 2012.” AIDS Between Science and Politics “, an updated English translation of”Le Sida dans le monde: entre science et politique“(2011), which explores the interplay of science, politics, and economics in the AIDS pandemic, was released in 2015.